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Abstract To address the potential role of the chemokine macro- 
phage inflammatory protein-2 (MIP-2) in airway inflammation, 
we examined whether MIP-2 may play a role in ozone-induced 
neutrophilic inflammation of airways and its modulation by dexa- 
methasone in rat lung. Following ozone exposure, MIP-2 mRNA 
expression in the lung peaked at 2 h after exposure and slowly 
declined thereafter. Dexamethasone suppressed ozone-induced 
MIP-2 mRNA expression and neutrophil accumulation in the 
lung. We suggest hat the MIP-2 mRNA induction may switch 
on the neutrophilic influx observed in this model of lung inflam- 
mation. Furthermore, the MIP-2 expression is regulated by dex- 
amethasone which may represent one of the mechanisms by which 
glucocorticoids exert their potent anti-inflammatory properties. 
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I. Introduction 
Acute ozone exposure of humans results in a significant 
decrease in lung function parameters and an increase in airway 
reactivity [1,2]. This effect has also been observed in dogs [3], 
guinea pigs [4] and rats [5]. Airway hyper-reactivity induced by 
ozone exposure is associated with epithelial injury [5-8] and an 
influx of inflammatory cells, mainly neutrophils [6,9,10]. Sev- 
eral studies have shown that neutrophils play a role in ozone- 
induced impairment of pulmonary function. In perfused rat 
lung, neutrophils potentiate the ozone-induced decrease in lung 
function and airway epithelial injury [5]. Furthermore, ozone- 
induced airway hyper-reactivity in dogs was prevented by neu- 
trophil depletion with hydroxyurea [3], Indeed, activated neu- 
trophils are known to release reactive oxygen radicals and pro- 
teolytic enzymes, both of which are capable of producing air- 
way reactivity [11] and tissue damage [12]. However, the mech- 
anisms by which neutrophils are recruited in the lung are poorly 
understood. 
Chemokines are a large group ofchemotactic and proinflam- 
matory cytokines [13,14]. They represents a family of polypep- 
tides, containing four conserved cysteine residues, which can be 
subdivided into two large groups depending on whether or not 
there is an intervening amino acid between the two cysteines 
yielding the C-X-C (or the ~) or C-C (or the fl) families. Mac- 
rophage inflammatory protein (MIP-2) is a 6 kDa basic protein 
purified from the endotoxin-stimulated macrophage RAW 
264.7 cell line [15]. The gene encoding MIP-2 has been cloned 
and the sequence shows the chemokine ~ subfamily of this 
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cytokine [16]. MIP-2 is a potent chemotactic agent for human 
polymorphonuclear leukocytes, and its in vivo injection results 
in neutrophil infiltration [15]. 
In this study, we investigate the effect of ozone exposure on 
the gene expression of MIP-2 mRNA in Brown-Norway rat 
lung and its modulation by glucocorticoids. We report that 
ozone exposure induces the expression of the chemokine M1P-2 
mRNA,  and that this expression may underlie the neutrophilic 
influx observed after ozone exposure. Furthermore, we show 
that the expression of MIP-2 mRNA is regulated by dexa- 
methasone. 
2. Materials and methods 
2.1. Ozone exposure 
Ozone was generated by passing laboratory air (1 l/min) through a 
Sander Ozoniser (Model IV; Sander GmbH, Germany). The output 
was diluted with compressed air (10 l/rain) controlled by a gas flowme- 
ter (Platon Flow Control, Basingstoke, UK) and fed into a 32 1 box. 
The concentration f ozone was determined by using specific gas sam- 
pling tubes (Dragerwerk, AG, Germany) and was maintained at 1 or 
3 ppm by regular measurement at he output port of the box. Pathogen- 
free Brown-Norway rats (25~350 g) were exposed to ozone for 2 or 
6 h, and as a control, rats inhaled filtered air only. 
2.2. Cell retrieval and counting 
Rats were administered an overdose of pentobarbitone (100 mg/kg 
intravenously), and lungs were lavaged with 20 ml of saline through a 
polyethylene tube introduced through the tracheotomy. Bronchoalveo- 
lar lavage (BAL) fluid was centrifuged and the cell pellet was resus- 
pended in 1 ml of Hanks' balanced salt solution. Using Kimura stain 
(dilution 1:10), total cell counts were made in a Neubauer chamber 
using light microscopy. Differential cell counts were performed on 
cytospin preparations stained by May-GriJnwald stain. Cells were iden- 
tified as macrophages, neutrophils, eosinophils, lymphocytes, baso- 
phils, and epithelial cells by standard morphology. After BAL, lung 
tissue was removed and stored at -70°C. 
2.3. Reverse transcription-polymerase chain reaction (RT-PCR) and 
sequencing 
For the preparation of MIP-2 cDNA, a Brown Norway rat was 
administered lipopolysaccharide (Escherichia coli; Sigma; 100 pg intra- 
tracheally). Total cellular RNA from rat BAL cells recovered 4 h later 
was isolated according to the method of Chomczynski and Sacchi [17]. 
Total cellular RNA from BAL cells recovered from LPS-stimulated rat 
was reverse transcribed in a 20,ul reaction volume with 1 x PCR buffer 
(10 mM Tris-HC1, pH 8.3, 50 mM KC1, 5 mM MgCI2), 2 mM dNTP, 
1 U RNasin (Promega, Madison), 17-base oligo-dT as primer and 7,5 
U reverse transcriptase at42°C for 60 min. PCR was performed on 1 pl 
of reverse transcriptase product as a final concentration of 1 x PCR 
buffer, 250/zM dNTP, 0.5 ,uM each of sense and antisense primers and 
2.5 U Taq polymerase (Promega, Southampton, UK) in a total volume 
of 40/11 using a thermal cycler (Techne, Cambridge, UK). The primers 
were designed from the published sequences for murine MIP-2 cDNA 
[16] as follows: sense-5'GGCACAATCGGTACGATCCAG and anti- 
sense-5'ACCCTGCCAAGGGTTGACTTC. Primers for glyceral- 
dehyde-3-phosphate dehydrogenase (GAPDH) were: sense 
5'TCCCTCAAGATTGTCAGCAA and antisense-5'AGATCCA- 
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CAACGGATACATT [18]. The PCR reagents were overlaid with min- 
eral oil and amplification was carried out through 25 30 cycles of 
denaturation at 95°C for 1 min, annealing at 60°C for 1 rain and 
extending at 72°C for 2 min. The PCR products were electrophoresed 
in 2% agarose gels to visualize the MIP-2 and GAPDH bands. The sizes 
of the PCR products generated were 287 bp for MIP-2 and 309 bp for 
GAPDH. The PCR product was excised and purified using Geneclean 
II (Stratech, Luton, UK). The purified products were used as cDNA 
probes for Northern blot analysis. The MIP-2 PCR product was also 
analysed by sequencing. Cycle sequence was performed on 100 ng of 
PCR product and 1 pmol of each primer. Cycling conditions were 30 s 
at 95°C, 30 s at 55°C and 30 s at 72°C using exo pfu- (Stratagene, 
Cambridge, UK). The purified product was used as cDNA probes for 
Northecn blot analysis. Sequence analysis of MIP-2 cDNA was homol- 
ogous to rat MIP-2 but not to other chemokines. 
2.4. Northern blot analysis 
The 287 bp MIP-2 PCR product and the 1272-bp PstI fragment from 
rat GAPDH cDNAs were labelled by random priming using 
[~-32p]dCTP (3000 Ci/mmol; Amersham, UK). Total cellular or mes- 
senger RNA from rat lung or bronchoalveolar l vage cells were sub- 
jected to electrophoresis ona 1% agarose/formaldehyde gel and blotted 
onto Hybond-N membranes (Amersham, UK). The prehybridization 
and hybridisation were carried out at 42°C in buffer containing 5x 
Denhardt's olution, 5 x standard saline citrate (SSC), 50 mM 
Na2HPO 4, 0.1% sodium dodecyl sulfate (SDS), 250 ,ul/ml sonicated 
denatured salmon sperm DNA and 50% formamide. Each blot was 
washed to a stringency of 0.1 x SSC, 0.1% SDS for 20 rain at 60°C and 
exposed at - 80°C for 1 7 days to Kodak X-OMAT S film. Autoradi- 
ographic bands were quantified by densitometric s anning (Quantity 
One software; PDI, New York, NY). 
2.5. Statistics 
Data are presented as mean + S.E.M. Statistical analysis of results 
was performed by Mann Whitney U-test for stepwise comparison. 
P values less than 0.05 were considered to be significant. 
3. Resu l ts  and d iscuss ion  
Recruitment of inf lammatory cells in the lungs may contrib- 
ute to tissue injury as a result of mediators released from these 
cells. Ozone exposure induces airway hyper-reactivity which is 
associated with a flux of inf lammatory cells, mainly neutro- 
phils, into the lung and airways of human and animals 
[2,6,9,10]. The molecular mechanisms underlying these re- 
sponses are poorly understood. The principal biological prop- 
erty of chemokines i their ability to attract and activate leuko- 
cytes [13,14]. In this study we investigated the gene expression 
of the chemokine MIP-2 following ozone exposure of BN rats 
and its modulat ion by dexamethasone. 
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Fig. 1. MIP-2 gene expression i lungs of Brown-Norway rats inhaling 
filtered air (CTRL) or exposed for 6 h to 3 ppm ozone (lanes 3-11). The 
lungs were removed at 2, 8 and 24 h after ozone exposure and assayed 
for MIP-2 mRNA expression. The top panel shows the Northern blot 
data with lung mRNA using the MIP-2 and the GAPDH cDNA 
probes. The estimated size for the MIP-2 mRNA transcript is 1.3 kb. 
The bottom panel represents the densitometric measurement of the 
Northern blot analyses. The level of MIP-2 mRNA expression was 
normalised to that of the GAPDH signal to account for differences in 
loading or transfer of the mRNA. Data are the mean _+ S.E.M. of 3-5 
observations. 
MIP-2 has been identified as a secretory product of mouse 
macrophages [15,19]. MIP-2 is chemotactic for neutrophils in 
vitro and can elicit a localised neutrophilic inflammation when 
injected subcutaneously in mice or when given intracisternally 
in rabbits [15,20]. MIP-2 has been shown to be increased in rat 
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Fig. 2. Effect of ozone on total cell number (right panel) and neutrophils (left panel) recovered by bronchoalveolar l vage in Brown Norway rats. 
After ozone exposure (3 ppm for 6 h), animals were lavaged at 2, 8 and 24 h after exposure. Control rats inhaled filtered air only (CTRL). Data 
are the mean + S.E.M. of 3 5 animals. *P < 0.05 compared to controls. 
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Fig. 3. Effect of dexamethasone on ozone-induced MIP-2 gene expres- 
sion. Rats were exposed to filtered air (CTRL), to 3 ppm ozone for 6 h 
(OZ), or treated with dexamethasone (3 mg/kg i.p. 1 h prior to ozone 
(DEX/OZ) or filtered air exposure (DEX)). Lung mRNA was extracted 
2 h after air or ozone exposure and assayed for MIP-2 mRNA expres- 
sion. The top panel shows the Northern blot data using the MIP-2 and 
the GAPDH cDNA probes. The lower panel shows the mean densito- 
metric measurements of the autoradiograms. Data are the 
mean +_ S.E.M. of 5-8 observations. *P < 0.05 compared to controls. 
lung after mineral dust exposure [21] or interleukin lfl instilla- 
tion [22]. 
In this study, we showed that ozone exposure of BN rats to 
3 ppm for 6 h results in increased expression of MIP-2 mRNA 
(Fig. 1). The MIP-2 mRNA signal was barely detectable in 
RNA obtained from animals exposed to filtered air only. The 
expression peaked at 2 h after exposure and rapidly declined 
thereafter. A similar profile of MIP-2 expression was found in 
bronchoalveolar lavage cells (data not shown). The MIP-2 in- 
duction was also seen after a shorter exposure time (2 h) and 
lower (1 ppm) ozone concentration (data not shown). 
Ozone-exposed rats also demonstrated a significant increase 
in neutrophil counts in BAL fluid without a significant change 
in total cell counts in BAL fluid (Fig. 2). The neutrophil recruit- 
ment was significantly increased at 2, 8 and 24 h post-ozone 
exposure. There was no significant difference in the number of 
macrophages, eosinophils, lymphocytes or epithelial cells re- 
covered in BAL fluid in animals exposed to ozone or inhaling 
filtered air. The MIP-2 mRNA expression preceded the in- 
crease in neutrophils. The delay between the increase in MIP-2 
mRNA and neutrophil recruitment may reflect he rate of MIP- 
2 protein turnover within the cells. These results suggest hat 
MIP-2 may be responsible, at least in part, for neutrophil nflux 
observed after ozone exposure. In support of this conclusion, 
it has been shown in a mouse model of inflammation i duced 
by mycobacterial ntigen that antiserum against MIP-2 was 
effective in reducing peritoneal neutrophilia [23]. The increase 
of MIP-2 mRNA at a time when there was a significant increase 
in neutrophil number might suggest the presence of additional 
stimuli for neutrophil recruitment. There are a number of fac- 
tors, including MIP-lct and cytokine-induced neutrophil 
chemoattractant (CINC), which are thought o play a role in in- 
flammatory cell recruitment [24,25]. In this respect, preliminary 
data from our laboratory suggest he induction by ozone of 
CINC mRNA in rat lung. Thus the contribution of other fac- 
tors in ozone-induced neutrophil accumulation is not excluded. 
There are several potential sources of MIP-2 in the lung, The 
most probable source is macrophages. Driscoll and Schlesinger 
[26] have shown that ozone stimulates alveolar macrophages to
release a chemotactic activity for neutrophils. Furthermore, 
macrophages obtained from BAL fluid have been previously 
shown to express MIP-2 mRNA following LPS stimulation 
[27,28]. MIP-2 mRNA has been recently shown to be induced 
by tumour necrosis factor in rat alveolar macrophages and in 
rat fibroblasts and epithelial cell lines [21]. Using in-situ hybrid- 
ization, Xu et al. [22] have demonstrated that following topical 
administration f IL-lfl, MIP-2 mRNA is detected in mononu- 
clear cells within the airway wall, with some contribution by 
epithelial cells. Thus, the macrophage and the airway epithe- 
lium are the most likely sources of increased expression we 
observed after in vivo exposure to ozone. 
Glucocorticoids are the most potent and effective agents in 
controlling chronic inflammatory disease [29]. Glucocorticoids 
have been shown to modulate the transcription of several genes 
by binding to a specific DNA sequence termed glucocorticoid 
response lements (GREs) located in the promoter egion of 
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Fig. 4. Effect of ozone and/or dexamethasone on the total cell number (A), and neutrophils (B) recovered by bronchoalveolar l vage in Brown Norway 
rats. After ozone exposure (3 ppm for 6 h), animals were lavaged at 2 h after exposure. Control rats inhaled filtered air only (CTRL). There was 
a significant increase in neutrophils (compared to control) which was significantly inhibited by dexamethasone pr -treatment (compared to ozone). 
Data are the mean + S.E.M. of 3-5 animals. 
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steroid-responsive target genes [29]. We have investigated 
whether the synthetic glucocorticoid, dexamethasone, could 
modulate the expression of MIP-2 mRNA. Dexamethasone 
alone had no effect on the level of MIP-2 mRNA expression. 
However, it significantly reduces the ozone-induced MIP-2 
mRNA expression to the control evel (Fig. 3). This inhibition 
was also reflected at the level of neutrophil nflux into the lung 
(Fig. 4). Indeed, dexamethasone significantly reduced ozone- 
induced neutrophilia in bronchoalveolar lavage fluid without 
having any effect on the total cell number, eosinophils or mac- 
rophages recovered in BAL fluid. (Fig. 4). 
In conclusion, we have shown that MIP-2 mRNA appears 
to be an important mediator in ozone-induced rat lung inflam- 
mation. We therefore suggest that the release of MIP-2 may be 
responsible, at least in part, for the recruitment of neutrophils 
observed in this model of ozone-induced lung inflammation. 
We have also demonstrated that the ozone-induced MIP-2 
mRNA expression is regulated by steroids in vivo and this 
could represent one of the mechanisms by which glucocorti- 
coids exert their potent anti-inflammatory properties. 
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